BioSpace News Archive

Genetown

Arbor Biotechnologies to Present at the Stifel 2023 Tailoring Genes: Genetic Medicines Day

Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, announced Devyn Smith, Ph.D., Arbor’s Chief Executive Officer, will present at the Stifel 2023 Tailoring Genes: Genetic Medicines Day.

May 23, 2023
·
1 min read
Pharm Country

Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform

Tiziana Life Sciences Ltd., a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, announced that they are now participating on the new Webull Corporate Communication services platform.

May 23, 2023
·
2 min read
OnKure Therapeutics Announces $54 Million Series C Financing

OnKure, Inc. a precision oncology company, today announced that it has successfully closed a $54 million Series C financing.

May 23, 2023
·
2 min read
Pharm Country

Tonix Pharmaceuticals Announces the Isolation and Characterization of the (S)-Isomer of Tianeptine, TNX-4300 (Estianeptine), Now Under Development for Psychiatric and Neurodegenerative Diseases

Tonix Pharmaceuticals today announced the isolation and functional characterization of the two mirror image isomers of racemic tianeptine, which is marketed outside the U.S. as a treatment for major depressive disorder (MDD).

May 23, 2023
·
10 min read
Business

Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator

Societal CDMO, Inc. today announced that it has been selected by Atossa Therapeutics (Nasdaq: ATOS ) to provide a range of its Clinical Trial Services (CTS) offerings focused on Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen.

May 23, 2023
·
5 min read
Biotech Bay

BioCardia Announces Timing of the Next Data Safety Monitoring Board Meeting for the CardiAMP Cell Therapy in Heart Failure Pivotal Study

BioCardia®, Inc. today announced that the next Data Safety Monitoring Board (DSMB) meeting for the CardiAMP Cell Therapy Trial for Heart Failure is scheduled to take place on July 12th.

May 23, 2023
·
3 min read
Drug Development

Zentalis to Host Investor Call to Provide Clinical Update with Safety, Pharmacology, and Efficacy Results for Azenosertib Monotherapy and Development Plans for Monotherapy and Chemotherapy Combinations

Zentalis ® Pharmaceuticals, Inc. today announced that the Company will host an investor update call to share the safety and efficacy results from its ongoing monotherapy dose optimization Phase 1 study of azenosertib, its potentially first-in-class WEE1 inhibitor product candidate.

May 23, 2023
·
5 min read
BioCapital

GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations

GeneDx today announced that it will participate in multiple presentations at the World Orphan Drug Congress in Washington, D.C., May 23-25, 2023.

May 23, 2023
·
3 min read
Bio NC

Allucent Launches Decentralized Clinical Trial Solution at 2023 World Orphan Drug Congress

Global biopharmaceutical services provider Allucent announced today that it has partnered with THREAD, an innovative DCT and eCOA technology provider, to launch Allucent Patient Direct Trials.

May 23, 2023
·
3 min read
Drug Development

Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study

Minghui Pharmaceutical, Inc., today announced that the phase 1a trial of MHB018A has commenced with the dosing of its first subject.

May 23, 2023
·
4 min read